ResearcherGerman Cancer Research CenterActive in the last 2 years
Claudia R. Ball
Matched on ORCID iD 0000-0002-1749-3791; OpenAlex author ID A5067826688, A5108948154. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper
Papers 5
- Biomarker screen for efficacy of oncolytic virotherapy in patient-derived pancreatic cancer cultures. Co-author DOI 10.1016/j.ebiom.2024.105219↗
- Virotherapy combined with anti-PD-1 transiently reshapes the tumor immune environment and induces anti-tumor immunity in a preclinical PDAC model. Co-author DOI 10.3389/fimmu.2022.1096162↗
- Systematic Generation of Patient-Derived Tumor Models in Pancreatic Cancer. Last author DOI 10.3390/cells8020142↗
- NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-18-0036↗
- Succession of transiently active tumor-initiating cell clones in human pancreatic cancer xenografts. Co-author DOI 10.15252/emmm.201607354↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Christine E. Engeland · 2 shared papers, 2022–2024 · strength 0.28
- Guy Ungerechts · 2 shared papers, 2022–2024 · strength 0.28
- Theresa E. Schäfer · 2 shared papers, 2022–2024 · strength 0.28
- Albrecht Stenzinger · 2 shared papers, 2018–2022 · strength 0.19
- Karl Roland Ehrenberg · 3 shared papers, 2017–2019 · strength 0.17
- Paper Systematic Generation of Patient-Derived Tumor Models in Pancreatic Cancer. DOI 10.3390/cells8020142↗
- Paper Succession of transiently active tumor-initiating cell clones in human pancreatic cancer xenografts. DOI 10.15252/emmm.201607354↗
- Paper NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer. DOI 10.1158/2159-8290.cd-18-0036↗
- Hanno Glimm · 3 shared papers, 2017–2019 · strength 0.17
- Paper Systematic Generation of Patient-Derived Tumor Models in Pancreatic Cancer. DOI 10.3390/cells8020142↗
- Paper Succession of transiently active tumor-initiating cell clones in human pancreatic cancer xenografts. DOI 10.15252/emmm.201607354↗
- Paper NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer. DOI 10.1158/2159-8290.cd-18-0036↗
- Florian Gebauer · 1 shared paper, 2024 · strength 0.15
- Rob C. Hoeben · 1 shared paper, 2024 · strength 0.15
- Lukas J.A.C. Hawinkels · 1 shared paper, 2024 · strength 0.15
- Selas T. F. Bots · 1 shared paper, 2024 · strength 0.15
- Vera Kemp · 1 shared paper, 2024 · strength 0.15
- Dirk Jäger · 1 shared paper, 2022 · strength 0.14
- Rūta Veinalde · 1 shared paper, 2022 · strength 0.14
- Jürgen Weitz · 2 shared papers, 2017–2019 · strength 0.12
- Oliver Strobel · 2 shared papers, 2018–2019 · strength 0.12
- Wilko Weichert · 2 shared papers, 2017–2018 · strength 0.10
- Moritz Koch · 1 shared paper, 2017 · strength 0.05
- Jens Werner · 1 shared paper, 2017 · strength 0.05
- Nathalia A. Giese · 1 shared paper, 2018 · strength 0.05
- Christoph Heining · 1 shared paper, 2018 · strength 0.05
- Thilo Hackert · 1 shared paper, 2018 · strength 0.05
- Marius Horger · 1 shared paper, 2018 · strength 0.05
- Christoph Springfeld · 1 shared paper, 2018 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.